Eyenovia Inc (EYEN) Announces Proposed Share Common Offering

Eyenovia, Inc. (NASDAQ: EYEN) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. In connection with this offering, Eyenovia expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock to be sold in the offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. All of the shares in the proposed offering are to be sold by Eyenovia.

Eyenovia intends to use the net proceeds from the public offering, together with existing funds, to fund the continued clinical development of its product candidates, initial commercialization activities for MicroStat, and for working capital and general corporate purposes.

William Blair & Company, L.L.C. is acting as sole book-running manager for the offering.

You May Also Be Interested In

• William Blair Starts Surrozen Inc. (SRZN) at Outperform
• Andersen prices secondary offering of 4.28M shares at $44 each
• Aptevo Therapeutics files prospectus for resale of 6.4M shares